Expression of interleukin-2 receptor α and CD45RO antigen on T lymphocytes cultured with rubella virus antigen, compared with humoral immunity in rubella vaccinees

被引:8
作者
Toyoda, M
Ihara, T
Nakano, T
Ito, M
Kamiya, H
机构
[1] Natl Mie Hosp, Dept Pediat, Tsu, Mie, Japan
[2] Mie Univ, Sch Med, Dept Pediat, Tsu, Mie 514, Japan
关键词
rubella; cell-mediated immunity; vaccination;
D O I
10.1016/S0264-410X(98)00412-5
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
We studied the expression of interleukin-2 receptor alpha (CD25)(+)CD45RO(+)CD4(+) T lymphocytes (T-cell activation) in response to the rubella virus (RV) antigen (Matsuura strain, Biken, Osaka, Japan) using three-color-staining Bow cytometry. The subjects were 48 healthy children (3-14 years old, 31 boys and 17 girls), who had received either monovalent vaccine (n = 5; mean age, 13.2 years) or measles-mumps-rubella (MMR) vaccine (n = 21; mean age, 10.5 years), had been naturally infected (n = 5; mean age, 11.4 years), or had been neither vaccinated nor naturally infected (n = 17; mean age, 10.0 years) and 62 healthy adolescents and adults (15-37 years old; 19 males and 43 females), who had received monovalent vaccine (n = 26, mean age, 27.4 years), had been naturally infected (n = 8; mean age, 24.0 years), or had been neither vaccinated nor naturally infected (n = 8, mean age, 16.5 years). Ninety-four of 110 subjects had HI titers greater than or equal to 1.16. T-cell activation in these subjects was significantly higher than that in 6 seronegative (HI titers < 1:8) subjects (p < 0.05). T-cell activation did not differ significantly with the history of exposure to RV. HI antibody liters greater than or equal to 1:16 and T-cell activation persisted in vaccinated subjects for greater than or equal to 20 years and was similar to those in naturally infected subjects. Our results suggest that cell-mediated immunity and humoral immunity persist for at least 20 years after vaccination. (C) 1999 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:2051 / 2058
页数:8
相关论文
共 22 条
[1]  
ASAHI T, 1997, VACCINE, V16, P1791
[2]  
BEST JM, 1992, INTERVIROLOGY, V34, P164
[3]   RUBELLA VACCINES - PAST, PRESENT AND FUTURE [J].
BEST, JM .
EPIDEMIOLOGY AND INFECTION, 1991, 107 (01) :17-30
[4]   RUBELLA REINFECTION - WHAT RISK TO THE FETUS [J].
BURGESS, MA .
MEDICAL JOURNAL OF AUSTRALIA, 1992, 156 (12) :824-825
[5]  
*CDC, 1990, MMWR-MORBID MORTAL W, V40, P93
[6]   RUBELLA ANTIBODY PERSISTENCE AFTER IMMUNIZATION - 16-YEAR FOLLOW-UP IN THE HAWAIIAN-ISLANDS [J].
CHU, SY ;
BERNIER, RH ;
STEWART, JA ;
HERRMANN, KL ;
GREENSPAN, JR ;
HENDERSON, AK ;
LIANG, AP .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1988, 259 (21) :3133-3136
[7]  
COOPER LZ, 1996, RUDOLPHS PEDIAT, P679
[8]   SEROLOGICAL EVIDENCE OF REINFECTION AMONG VACCINEES DURING RUBELLA OUTBREAK [J].
CUSI, MG ;
ROSSOLINI, GM ;
VALENSIN, PE ;
CELLESI, C ;
ZANCHI, A .
LANCET, 1990, 336 (8722) :1071-1071
[9]  
HILLARY I B, 1984, Vaccine, V2, P274, DOI 10.1016/0264-410X(84)90043-4
[10]  
HORSTMANN DM, 1985, REV INFECT DIS S1, V7, P80